PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 3, 2026World Journal of Gastrointestinal Oncology0 citationsOpen Access

Clinical efficacy of Fuzheng Jiedu Xiaoyong granules in advanced colorectal cancer (spleen deficiency and stasis toxin syndrome)

View Full Paper
HQHai-Yun QinZLZheng LiPCPei-Wei Cong

Key Points

  • Fuzheng Jiedu Xiaoyong granules effectively reduce chemotherapy-induced toxicities and enhance immune function.
  • Clinically, these granules alleviate symptoms in patients suffering from advanced colorectal cancer and spleen deficiency.

Structured PICO

Does Fuzheng Jiedu Xiaoyong granules improve clinical symptoms, enhance immune function, and reduce chemotherapy-induced toxicities in patients with advanced colorectal cancer with spleen deficiency and stasis toxin syndrome?

P
Population
Patients with advanced colorectal cancer (CRC) with spleen deficiency and stasis toxin syndrome
I
Intervention
Fuzheng Jiedu Xiaoyong granules (FZJDXYG)
O
Outcome
Clinical symptoms, immune function, and chemotherapy-induced toxicities

Fuzheng Jiedu Xiaoyong granules may improve symptoms, enhance immune function, and reduce chemotherapy toxicity in advanced colorectal cancer patients with specific traditional Chinese medicine syndromes.

Abstract

FZJDXYG effectively ameliorates clinical symptoms, enhances immune function, and reduces chemotherapy-induced toxicities in patients with advanced CRC with spleen deficiency and stasis toxin syndrome.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Qin et al. (2026) studied this question.

synapsesocial.com/papers/69a7657ebadf0bb9e87d94c8https://doi.org/10.4251/wjgo.v18.i2.113922
Ask AI
Helpful
Bookmark
Share
View Full Paper